Title : Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate.

Pub. Date : 2017 Apr

PMID : 27748083






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Significant decreases from baseline in the Disease Activity Score in 28 joints using the C-reactive protein level were seen in the peficitinib 50 mg (P < 0.05) and 150 mg (P < 0.01) groups compared with placebo at week 12. peficitinib C-reactive protein Homo sapiens